Teva CEO responds to 25% share price fall
Teva CEO Richard Francis said that he had not expected such a harsh reaction from the market but he sees a positive side to ...
Pharm Exec11d
The Teva Turnaround: Steering a Company Comeback
CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...
GlobalData on MSN6d
New CEOs to join Merck KGaA’s executive board
Jean-Charles Wirth and Danny Bar-Zohar are set to assume the life science and healthcare CEO roles respectively.
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit ...
Le Lézard7d
ICC Arbitral Tribunal Rules in Favor of AOP Health in Arbitration Proceedings Pertaining to BESREMi® (Ropeginterferon alfa-2b)
Today, a tribunal under the auspices of the International Chamber of Commerce (ICC) served a partial final award in a dispute between PharmaEssentia Corp. ("PharmaEssentia") and AOP Orphan ...
Yahoo Finance29d
Human Growth Hormone Market Size is Expected to Reach USD 18.75 Billion by 2033, Growing at a CAGR of 11.90%: Straits Research
New York, United States, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Somatotropin, or human growth hormone, is a peptide hormone made by the pituitary gland that controls cell growth, reproduction ...
pharmaphorum2d
Pfizer confirms $160bn reverse takeover of Allergan
If and when approved by shareholders and regulators, the combined company will retain Pfizer's global operational headquarters in ... its generics business to Teva, which is expected to be ...